Neurosteroids, which are synthesized in the brains of humans and other mammals, are under investigation for use in a range of human health conditions (e.g., anxiety, memory, immune function, problems associated with aging). One of these compounds, dehydroepiandrosterone (DHEA), is a powerful inhibitor of aggression in murine models when given for fifteen days and potentially may be useful in the management of inappropriate human aggression. Although the biosynthesis and metabolism of DHEA have been described, a significant gap exists concerning the mechanism(s) of this anti-aggressive effect. We know that 15 days of DHEA treatment reduces whole brain levels of pregnenolone sulfate (PREG-S), a GABAA receptor antagonist that works directly at the membrane level, and we recently discovered that DHEA also up-regulates androgen receptor (AR) in the limbic system, demonstrating a genomic effect. Both events can contribute to enhanced GABA activity, an inhibitory neurotransmitter known to reduce aggression. The major goal of the proposed research, therefore, will be to identify and/or quantitate the metabolic, membrane level, and genomic effects of extended DHEA treatment and then determine the contributions of each to the aggression- inhibiting effect of this neurosteroid. Experiments will be undertaken to localize the specific brain regions where DHEA treatment causes a significant decline in PREG-S, characterize the regional changes in GABAA receptor binding that occur over the course of DHEA exposure, define effects of the androgenic metabolites of DHEA on AR regulation that may be linked to the anti-aggressive action of this neurosteroid and, finally, perform functional biobehavioral and in vivo microinfusion studies involving pharmacological manipulations to begin defining underlying neural regulatory mechanisms. The results should achieve two objectives. One is that critical mechanisms and sites of action for the inhibition of aggression by DHEA will be defined, advancing models of the neurobiology of this behavior. The other is that with the characterization of both membrane-level and genomic actions linked to the anti- aggressive effect of DHEA, a """"""""cross-talk"""""""" cellular signaling system associated with extended neurosteroid treatment would be established. This finding would significantly advance our understanding of the mechanism of action of DHEA, an important consideration given proposed clinical uses.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
1R01MH059300-01A2
Application #
6196354
Study Section
Special Emphasis Panel (ZRG1-IFCN-2 (01))
Program Officer
Winsky, Lois M
Project Start
2000-08-10
Project End
2004-07-31
Budget Start
2000-08-10
Budget End
2001-07-31
Support Year
1
Fiscal Year
2000
Total Cost
$223,881
Indirect Cost
Name
Lehigh University
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
City
Bethlehem
State
PA
Country
United States
Zip Code
18015
Mo, Qianxing; Lu, Shifang; Garippa, Carrie et al. (2009) Genome-wide analysis of DHEA- and DHT-induced gene expression in mouse hypothalamus and hippocampus. J Steroid Biochem Mol Biol 114:135-43
Mo, Qianxing; Lu, Shi-fang; Simon, Neal G (2006) Dehydroepiandrosterone and its metabolites: differential effects on androgen receptor trafficking and transcriptional activity. J Steroid Biochem Mol Biol 99:50-8
Ferris, Craig F; Lu, Shi-Fang; Messenger, Tara et al. (2006) Orally active vasopressin V1a receptor antagonist, SRX251, selectively blocks aggressive behavior. Pharmacol Biochem Behav 83:169-74
Simon, Neal G; Mo, Qianxing; Hu, Shan et al. (2006) Hormonal pathways regulating intermale and interfemale aggression. Int Rev Neurobiol 73:99-123
Hu, Shan; Lu, Shi-Fang; Kaplan, Jay R et al. (2005) ERbeta protein expression in female cynomolgus monkey and CF-1 mouse brain: Western analysis. J Neurobiol 64:298-309
Simon, Neal G; Kaplan, Jay R; Hu, Shan et al. (2004) Increased aggressive behavior and decreased affiliative behavior in adult male monkeys after long-term consumption of diets rich in soy protein and isoflavones. Horm Behav 45:278-84
Mo, Qianxing; Lu, Shi-Fang; Hu, Shan et al. (2004) DHEA and DHEA sulfate differentially regulate neural androgen receptor and its transcriptional activity. Brain Res Mol Brain Res 126:165-72
Lu, Shi-Fang; Mo, Qianxing; Hu, Shan et al. (2003) Dehydroepiandrosterone upregulates neural androgen receptor level and transcriptional activity. J Neurobiol 57:163-71